P.J.H. Jongen

Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS

Ludwig Kappos, Anthony Traboulsee, Cris S. Constantinescu et al. · Neurology · 2006 · 255 citations

Life Sciences, Neurology, Pharmacotherapy +14

Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy

Saskia A. Rutjes, W.T.M. Vree Egberts, P.J.H. Jongen et al. · Clinical & Experimental Immunology · 1997 · 202 citations · Full text

Life Sciences, Immunology, Pathology +17

Long-term safety and efficacy of teriflunomide

Paul O’Connor, Mark S. Freedman, Aaron Miller et al. · Neurology · 2016 · 126 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Clinical and serological characteristics of 125 Dutch myositis patients

G.J.D. Hengstman, R M Brouwer, W.T.M. Vree Egberts et al. · Journal of Neurology · 2002 · 106 citations

Life Sciences, Immunology, Internal Medicine +12

Association between MRI parameters and the MS severity scale: a 12 year follow-up study

A. Minneboo, P.J.H. Jongen, Hugo Vrenken et al. · Multiple Sclerosis Journal · 2009 · 38 citations

Medicine, Neurology, Neuroscience +16